Source: Medical Buyer

Baxterbiopharmasolutions: Baxter BioPharma solutions announces $50 million investment to expand Sterile fill/finish manufacturing site in Bloomington, Ind.

Construction currently underway; expected to be completed in 2021 Expanded facilities expected to support approximately 100 new jobs locally Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production...Read More

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100